Publications
Publications
Show Results For
- All HBS Web
(1,467)
- Faculty Publications (396)
COVID-19
→
- May 2022
- Case
Deborah Quazzo at GSV Ventures
By: William A. Sahlman, Michael D. Smith and Nicole Tempest Keller
As COVID-19 swept across the globe in 2020, the education sector faced unprecedented disruption. Schools and colleges worldwide shut down, forcing over a billion students and teachers to move to online learning. Investor interest in the EdTech space exploded as... View Details
- May 2022
- Article
The Impact of COVID-19 on Digital Communication Patterns
By: Evan DeFilippis, Stephen Michael Impink, Madison Singell, Jeff Polzer and Raffaella Sadun
We explore the impact of COVID-19 on employees’ digital communication patterns through an event study of lockdowns in 16 large metropolitan areas in North America, Europe, and the Middle East. Using de-identified, aggregated meeting and email meta-data from 3,143,270... View Details
- May 2022 (Revised April 2024)
- Case
Third Point in 2020: Growth Is Where the Value Is?
By: Robin Greenwood, James Williams and Denise Han
In early May 2020, Daniel Loeb’s team at Third Point was evaluating a potential growth opportunity in the Walt Disney Company and whether investor activism might play a role. Battered by the effects of COVID-19, the company’s stock had initially tumbled to $86 and then... View Details
- May 2022
- Case
Executive Decision-Making at Zola
By: Amy C. Edmondson and Michael Roberto
In April 2020, Rachel Jarrett, President and COO of wedding technology company Zola, called a meeting with the organization’s key decision-makers. The company had previously launched three business expansions: a vendor marketplace, a wedding apparel division, and a... View Details
- 2022
- Working Paper
Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina
By: Sebastian Calonico, Rafael Di Tella and Juan Cruz Lopez Del Valle
Many medical decisions during the pandemic were made without the support of causal evidence obtained in clinical trials. We study the case of nebulized ibuprofen (NaIHS), a drug that was extensively used on COVID-19 patients in Argentina amidst wild claims about its... View Details
- Article
Early Withdrawal of Pandemic Unemployment Insurance: Effects on Earnings, Employment and Consumption
By: Kyle Coombs, Arindrajit Dube, Calvin Jahnke, Raymond Kluender, Suresh Naidu and Michael Stepner
In June 2021, 22 states ended all supplemental pandemic unemployment insurance (UI) benefits, eliminating benefits entirely for over 2 million workers and reducing benefits by $300 per week for over 1 million workers. Using anonymous bank transaction data and a... View Details
- May 27, 2022
- Article
How 'Digital Nomad' Visas Can Boost Local Economies
More and more companies are offering their employees the option to “work from anywhere,” whether in their home office, in another state, or even halfway around the globe. A growing group of remote professionals are taking the “anywhere” in work-from-anywhere to new... View Details
- 2022
- Chapter
Lessons Learned from Support to Business during COVID-19
By: Gabriel Chodorow-Reich, Benjamin Iverson and Adi Sunderam
The authors survey the new federal subsidies and loans provided to businesses in the first year of the pandemic—including the Paycheck Protection Program (PPP), the Economic Injury Disaster Loan (EIDL) program, and aid targeted at specific industries such as airlines... View Details
- 2022
- Book
O Coração do Negócio Os princípios de liderança e a chave para o sucesso
By: Hubert Joly and Caroline Lambert
A remarkable turnaround by a leader with a remarkable philosophy: Find your noble purpose. Put people at the center. Unleash human magic.
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Retail Industry; Pharmaceutical Industry; Health Industry; United States
- April 12, 2022
- Article
Evaluation of Individual and Ensemble Probabilistic Forecasts of COVID-19 Mortality in the United States
By: Estee Y. Cramer, Evan L. Ray, Velma K. Lopez, Johannes Bracher, Andrea Brennen, Alvaro J. Castro Rivadeneira, Michael Lingzhi Li and et al.
Short-term probabilistic forecasts of the trajectory of the COVID-19 pandemic in the United States have served as a visible and important communication channel between the scientific modeling community and both the general public and decision-makers. Forecasting models... View Details
- April 2022
- Case
Connecting Students in Chattanooga (A)
By: Jan W. Rivkin and Manjari Raman
As COVID-19 hit and school buildings closed across America in the spring of 2020, tens of thousands of K-12 students in Chattanooga’s Hamilton County lacked the high-quality Internet service required to connect them to remote education. Bryan Johnson, superintendent... View Details
- April 2022
- Supplement
Connecting Students in Chattanooga (B)
By: Jan W. Rivkin and Manjari Raman
- 2022
- Book
企業初心 未來企業的新領導準則
By: Hubert Joly and Caroline Lambert
A remarkable turnaround by a leader with a remarkable philosophy: Find your noble purpose. Put people at the center. Unleash human magic.
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
- 2022
- Book
하트 오브 비즈니스 미래의 비즈니스를 위한 안내서
By: Hubert Joly and Caroline Lambert
A remarkable turnaround by a leader with a remarkable philosophy: Find your noble purpose. Put people at the center. Unleash human magic.
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
- 2022
- Book
商业的核心 新时代的企业经营原则 世界500强百思买前掌门人作品 贝佐斯推荐
By: Hubert Joly and Caroline Lambert
A remarkable turnaround by a leader with a remarkable philosophy: Find your noble purpose. Put people at the center. Unleash human magic.
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
"It was fall in Minnesota. It was getting cold and we were supposed to die." This is how Hubert Joly describes the early,... View Details
- Article
Creating High-Impact Coalitions: CEOs Can Lead the Charge on Society’s Biggest Problems
By: Rosabeth M. Kanter and Tuna Cem Hayirli
Traditionally, responses to crises and societal problems—the COVID-19 pandemic, natural disasters, racial inequities—are considered the responsibility of the public sector and NGOs. But addressing the world’s most critical problems requires leadership, resources, and... View Details
- 2022
- Working Paper
THEMIS: A Framework for Cost-Benefit Analysis of COVID-19 Non-Pharmaceutical Interventions
By: Dimitris Bertsimas, Michael Lingzhi Li and Saksham Soni
Since December 2019, the world has been ravaged by the COVID-19 pandemic, with over 150 million confirmed cases and 3 million confirmed deaths worldwide. To combat the spread of COVID-19, governments have issued unprecedented non-pharmaceutical interventions (NPIs),... View Details
Keywords: COVID-19; Health Pandemics; Policy; Framework; Cost vs Benefits; Outcome or Result; United States; Germany; Brazil; Singapore; Spain
- March 2022 (Revised March 2024)
- Case
DaVita Responds to COVID
By: Susanna Gallani and David Lane
Early in August 2021, DaVita CEO Javier Rodriguez was assessing the ongoing impact of the COVID-19 pandemic on his firm, which provided life-sustaining kidney dialysis to roughly 240,000 people. Effective infection control practices and information sharing had ensured... View Details
Keywords: COVID-19 Pandemic; Change Management; Communication; Talent and Talent Management; Fairness; Values and Beliefs; Corporate Accountability; Health Care and Treatment; Health Pandemics; Human Resources; Employee Relationship Management; Retention; Wages; Working Conditions; Leadership Style; Crisis Management; Organizational Culture; Health Industry; United States
- 2022
- Article
The Great Resignation Didn't Start with the Pandemic
By: Joseph B. Fuller and William R. Kerr
COVID-19 spurred on the Great Resignation of 2021, during which record numbers of employees voluntarily quit their jobs. But what we are living through is not just short-term turbulence provoked by the pandemic. Instead, it’s the continuation of a trend of rising quit... View Details